Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07339215 · ClinicalTrials.gov registry record · NA
Local Antibiotic Concentrations With Tissue Expanders in Breast Reconstruction
A NA study, sponsored by University of California, Davis.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07339215 is a NA study that has not yet begun recruiting, run by University of California, Davis. The registered enrollment target is 100 participants.
The verdict
NCT07339215, a NA study, has not yet begun recruiting, sponsored by University of California, Davis.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Infections after tissue expander breast reconstruction can lead to pain, additional surgeries, and loss of the reconstruction. This study will compare two types of antibiotic carriers used during surgery to help lower the risk of infection. One carrier is a non-absorbable PMMA disc, and the other is an absorbable antibiotic bead. Both release antibiotics directly into the breast pocket after surgery. About 100 patients will be randomly assigned to receive one of these two carriers at the time of tissue expander placement. After surgery, small samples of fluid around the tissue expander will be collected during routine clinic visits. These samples will be tested to measure how much antibiotic is present over time. The study will also track infections, tissue expander loss, and other complications during the first 90 days after surgery. The goal is to learn how much antibiotic each carrier delivers and whether one method is more effective at preventing infection.
Interventions
- DEVICE Antibiotic loaded calcium sulfate beads
- DEVICE Polymethylmethacrylate antibiotic disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07339215
The ClinicalTrials.gov registry entry for NCT07339215 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Antibiotic loaded calcium sulfate beads is the first listed.
NCT07339215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07339215 about?
NCT07339215 is a clinical study titled "Local Antibiotic Concentrations With Tissue Expanders in Breast Reconstruction". Infections after tissue expander breast reconstruction can lead to pain, additional surgeries, and loss of the reconstruction. This study will compare two types of antibiotic carriers used during surgery to help lower the risk of infection. One carrier is a non-absorbable PMMA disc, and the other is...
What is the current status of trial NCT07339215?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07339215?
The interventions under investigation include: Antibiotic loaded calcium sulfate beads (DEVICE), Polymethylmethacrylate antibiotic disc (DEVICE).
Who is sponsoring clinical trial NCT07339215?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.